Skip to main content
. 2016 Oct 24;7(46):76250–76260. doi: 10.18632/oncotarget.12841

Table 1. Demographic and clinical features of the study population.

Variable Non-recurrent, n (%) Recurrent, n (%) P valuea
Age (years)
  ≤57 28 (49) 16 (59) 0.385
  >57 29 (51) 11 (41)
Sex
  Male 36 (63) 17 (63) 0.986
  Female 21 (37) 10 (37)
Race
  White 39 (68) 16 (59) 0.409
  Non-white 18 (32) 11 (41)
Location
  Cecum/transverse/descending colon 19 (33) 2 (7) 0.029b
  Ascending colon 17 (30) 10 (37)
  Sigmoid 21 (37) 15 (56)
CEA (μg/L)
  ≤5 52 (91) 22 (82) 0.279
  >5 5 (9) 5 (19)
Tumor stage
  IIA 6 (11) 3 (11) 0.191b
  IIB, IIC 2 (4) 0 (0)
  IIIA 4 (7) 0 (0)
  IIIB 33 (58) 13 (48)
  IIIC 12 (21) 11 (41)
Tumor differentiation
  Moderate to well, well 44 (77) 22 (82) 0.655
  Moderate to poor, poor 13 (23) 5 (19)
Lymph vascular invasion
  No 45 (79) 23 (85) 0.497
  Yes 12 (21) 4 (15)
Perineural invasion
  No 42 (74) 19 (70) 0.750
  Yes 15 (26) 8 (30)
Margin positive
  No 23 (40) 8 (30) 0.342
  Yes 34 (60) 19 (70)
Lymph nodes resected
  2-10 32 (56) 15 (56) 0.664
  11-25 5 (9) 1 (4)
  25-65 20 (35) 11 (41)
Lymph nodes involved
  0 7 (12) 3 (11) 0.030
  1-5 40 (70) 12 (44)
  >5 10 (18) 12 (44)
Adjuvant chemotherapy
  None or missing 2 (4) 3 (11) 0.424
  FOLFOX 47 (82) 19 (70)
  Other 8 (14) 5 (19)
a

Two-sided Chi-square test.

b

Fisher's exact test.